Baylor College of Medicine News

Molecular and Cellular Biology News

Mother's diet before pregnancy may affect child’s lifelong risk of cancerJun 11, 2015
Study finds mother’s diet around the time of conception can change the function of certain genes in her child, including the gene associated with cancer risk.
Baylor College of Medicine's Duncan Cancer Center receives additional $15.9 million in state cancer funding May 29, 2015
Researchers in the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine have received $15.9 million from the Cancer Prevention and Research Institute of Texas for two new large grants focused on liver cancer and prostate cancer.
Interaction of estrogen receptor and coactivators seen for first timeFeb 26, 2015
Study uses electron cryo-microscope and advanced computational analysis to help visualize 3-D image of how the estrogen receptor works.
Coactivator forges pathway for prostate cancer metastatic survivalFeb 16, 2015
New finding could help define pathway to develop a drug against prostate cancer metastasis, according to researchers at Baylor.
O’Malley receives Outstanding Innovation Award from Endocrine SocietyJan 14, 2015
Dr. Bert O’Malley, chair of molecular and cellular biology at Baylor College of Medicine, has been named as the recipient of the Endocrine Society’s Outstanding Innovation in Science Award.
Dr. Atul Chopra named Caroline Wiess Law ScholarDec 31, 2014

Dr. Atul Chopra has been named a Caroline Wiess Law Scholar, an award designated to recruit and retain accomplished, young physician-scientists.

'Wound response' of cancer stem cells may explain chemo-resistance in bladder cancerDec 3, 2014
A novel mechanism – similar to how normal tissue stem cells respond to wounding – might explain why bladder cancer stem cells actively contribute to chemo-resistance after multiple cycles of chemotherapy drug treatment.
$160,000 NIH grant advances mining of datasets in scientific articlesOct 21, 2014
Award will help informatics team explore ways to enable researchers to analyze or mine such datasets more easily.
SRC-2 drives castration-resistant prostate cancerOct 9, 2014
Finding a blocker for the nuclear receptor coactivator known as NCoA2 or SRC-2 might solve the problem of treating advanced prostate cancer that becomes resistant to the most common treatment.
Study shines new light on genetic alterations of aggressive breast cancer subtypeAug 7, 2014
Researchers find genetic alterations that may contribute to the development of a subtype breast cancer typically associated with more aggressive forms of the disease and higher recurrence rates.